DNLI
Closed
Denali Therapeutics Inc
13.95
-0.04 (-0.29%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 13.99
Day's Range: 13.83 - 14.66
Send
sign up or login to leave a comment!
When Written:
23.04
Denali Therapeutics Inc. is a biotechnology company focused on developing therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. The company was founded in 2015 by a group of scientists with extensive experience in neuroscience drug discovery and development. Denali's approach involves using cutting-edge technologies to identify and develop therapies that target the underlying causes of these diseases. The company's pipeline includes several drug candidates in various stages of development, including DNL747 for Alzheimer's disease and DNL310 for Hunter syndrome. Denali is headquartered in South San Francisco, California and is publicly traded on the NASDAQ under the ticker symbol "DNLI".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








